Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare
Crinetics Pharmaceuticals Inc. Shareholder Equity 2016–2025
Crinetics Pharmaceuticals Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Crinetics Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 992.1M, a 25.11% decrease year-over-year.
- Crinetics Pharmaceuticals Inc. shareholder equity for 2025 were 992.1M, a 25.11% decrease from 2024.
- Crinetics Pharmaceuticals Inc. shareholder equity for 2024 were 1.32B, a 145.74% increase from 2023.
- Crinetics Pharmaceuticals Inc. shareholder equity for 2023 were 539.1M, a 70.43% increase from 2022.
- Crinetics Pharmaceuticals Inc. shareholder equity for 2022 were 316.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crinetics Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $992 |
| 2024 | $1,325 |
| 2023 | $539 |
| 2022 | $316 |
| 2021 | $332 |
| 2020 | $169 |
| 2019 | $117 |
| 2018 | $160 |
| 2017 | $-15 |
Crinetics Pharmaceuticals Inc. Shareholder Equity — FAQ
Crinetics Pharmaceuticals Inc. (CRNX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRNX's shareholder equity history?
The chart and table above show Crinetics Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.